This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
This piece explains how wash sale rules affect Dividend Etf losses, with practical strategies to stay compliant and preserve tax benefits.
20,109 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Two Vanguard growth options vie for dominance in a shifting market. This guide breaks down vanguard growth growth etf...
Oil prices near $100 a barrel collide with Brazil's sugar-and-ethanol balance, threatening tighter sugar supplies jus...
Choosing between a climate-focused global ETF and an emerging markets fund isn’t just about returns. This guide break...
A new space-focused ETF is turning heads with strong gains this year. While SpaceX IPO excitement helps, the fund’s b...
Tech stocks grab headlines, but a smart shift toward dividend-focused value can offer resilience and growth. Learn wh...
In a volatile start to 2026, investors are seeking dividend ETFs built survive strategies that combine durable income...
A major investment manager disclosed a sizable share disposal in a U.S. utility stock through an SEC filing. The move...
When a company posts a robust quarter, insider stock moves often draw attention. This article unpacks the sale by the...
If you want safe dividend income, you don’t have to chase flashy yields. This guide lays out a practical plan to buil...
As of June 22, 2026, Vanguard’s international dividend ETF is delivering a higher yield and stronger year-to-date per...
When an asset manager sells million shares of a popular bond ETF, it can signal shifts in liquidity and portfolio str...